share_log

Ginkgo Bioworks(DNA.US)董事增持62.5万股普通股股份,价值约51.48万美元

Ginkgo Bioworks(DNA.US) Director Buys US$514.75K in Common Stock

Futu News ·  May 17 05:52

$Ginkgo Bioworks (DNA.US)$ Director Sankar Shyam purchased 625K shares of common stock on May 15, 2024 at an average price of $0.8236 for a total value of $514.75K.

1715896322371959881.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment